Internal Medicine · Brooklyn, NY
NPI
1215949219
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1009 Brighton Beach Ave, Suite 304
Brooklyn, NY, 11235
Phone (718) 975-0657
Groups this clinician bills Medicare through
Medicare paid, 2024
$198K
4,586 services
Medicare patients, 2024
504
Average age 78
Drug cost, 2024
$2.6M
12,390 prescriptions
Company payments, 2025
$1,357
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vitaly Volovoy was code 99213 (office e&m - established), 1,028 times for 412 patients. In total Vitaly Volovoy billed 4,586 services in 61 codes, and Medicare paid $198K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,028 | 412 | $65.72 | $68K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 879 | 142 | $53.62 | $47K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 674 | 131 | $41.66 | $28K |
| 93000 Electrocardiogram | Office | 328 | 238 | $10.16 | $3,334 |
| 36415 Venipuncture Blood Collection | Office | 321 | 253 | $8.65 | $2,777 |
| 99211 Office E&M - Established | Office | 184 | 110 | $19.11 | $3,516 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 133 | 112 | $28.14 | $3,742 |
| 96372 Injection Administration | Office | 112 | 55 | $10.28 | $1,151 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 105 | 42 | $0.93 | $97.81 |
| 99214 Office E&M - Established | Office | 80 | 72 | $99.42 | $7,953 |
| 99212 Office E&M - Established | Office | 73 | 36 | $42.16 | $3,077 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 55 | 31 | $0.95 | $52.42 |
| 96365 Intravenous Infusion, Hydration | Office | 55 | 31 | $49.25 | $2,709 |
| 93922 Duplex Scan - Extremity Arteries | Office | 54 | 54 | $67.37 | $3,638 |
| 95921 Electrical Nerve Conductivity | Office | 53 | 53 | $75.00 | $3,975 |
By year: 2022 $260K for 5,050 services; 2023 $209K for 4,322 services; 2024 $198K for 4,586 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 321 | 253 | $8.65 | $2,777 |
| 82947 Clinical Chemistry | 23 | 20 | $3.85 | $88.55 |
Medicare prescription drug claims, 2024
In 2024, the drug Vitaly Volovoy prescribed most often to Medicare patients was Amlodipine Besylate, with 554 prescriptions and refills. In total Vitaly Volovoy wrote 12,390 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 554 | 728 | 98 | $1,128 |
| Diclofenac Sodium Generic | 531 | 577 | 87 | $213K |
| Atorvastatin Calcium Generic | 428 | 640 | 92 | $1,765 |
| Metoprolol Succinate Generic | 395 | 535 | 75 | $2,372 |
| Rosuvastatin Calcium Generic | 395 | 503 | 62 | $1,904 |
| Synthroid Levothyroxine Sodium | 387 | 443 | 40 | $13K |
| Omeprazole Generic | 287 | 341 | 50 | $964 |
| Linzess Linaclotide | 278 | 340 | 52 | $173K |
| Eliquis Apixaban | 236 | 270 | 41 | $158K |
| Metformin Hcl Generic | 222 | 340 | 44 | $585 |
| Vascepa Icosapent Ethyl | 214 | 237 | 33 | $79K |
| Clopidogrel Clopidogrel Bisulfate | 203 | 290 | 35 | $757 |
| Glimepiride Generic | 188 | 270 | 23 | $562 |
| Levothyroxine Sodium Generic | 179 | 256 | 22 | $713 |
| Losartan Potassium Generic | 173 | 258 | 37 | $576 |
Brand drugs: 3,335 claims; generic drugs: 8,780 claims; opioid claims: 57.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vitaly Volovoy $1,357 ($1,357 in general payments such as food, travel and fees) from 15 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $276.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $276 |
| Genzyme Corporation SNY | 2 | $182 |
| Abbvie Inc. ABBV | 9 | $171 |
| Sumitomo Pharma America, Inc. 4506.T | 10 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $106 |
| Novo Nordisk Inc NVO | 4 | $85.51 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $73.6 |
| Aimmune Therapeutics, Inc. | 2 | $62.13 |
| Astellas Pharma US Inc 4503.T | 2 | $61.92 |
| Almatica Pharma LLC | 3 | $58.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.